Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The endogenous cannabinoid (eCB) system represents a major therapeutic target for the treatment of a variety of anxiety-related disorders. A recent study has demonstrated that pharmacologic or genetic disruption of CB1-receptor-mediated neurotransmission decreases the extinction of conditioned fear in mice. Here, we examined whether CB1 blockade would similarly disrupt extinction in rats, using fear-potentiated startle as a measure of conditioned fear. We also examined whether pharmacologic enhancement of CB1 activation would lead to enhancements in extinction. Our results indicate that systemic administration of the CB1 antagonist rimonabant (SR141716A) prior to extinction training led to significant, dose-dependent decreases in extinction. While the administration of the CB1 agonist WIN 55,212-2 did not appear to affect extinction, administration of AM404, an inhibitor of eCB breakdown and reuptake, led to dose-dependent enhancements in extinction. In addition to showing decreased fear 1 and 24 h after extinction training, AM404-treated animals showed decreased shock-induced reinstatement of fear. Control experiments demonstrated that the effects of AM404 could not be attributed to alterations in the expression of conditioned fear, locomotion, shock reactivity, or baseline startle, as these parameters seemed unchanged by AM404. Furthermore, coadministration of rimonabant with AM404 blocked this enhancement of extinction, suggesting that AM404 was acting to increase CB1 rece…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The endocannabinoid system has also been implicated in conditioned fear extinction and represents an additional area of exploration for facilitating extinction and prevention of fear return.”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [83]
In the citing paper
“Chhatwal et al. (83) showed that enhanced cannabinoid receptor CB1 activation (via administration of AM404, an agent that prevents endocannabinoid degradation and reuptake) facilitated within-session and between-session extinction of fear-potentiated startle as well as reinstatement in mice (83).”
From Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors (2014) · cites this paper as [83]
In the citing paper
“Activating CB1R via systemic or intra-hippocampal or -mPFC administration of either the CB1R agonist, WIN55212-2, the ECB reuptake blocker, AM404, or AEA itself has been shown to facilitate rodent fear extinction, in most cases without affecting conditioned fear [89,95–98] (but see [90]).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [96]
Citations
Cites
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · cited 1×
“Recent studies of CB1 knockout mice have demonstrated that the genetic deletion of the CB1 receptor leads to increased anxiety in several well-studied measures (Haller et al, 2002, 2004a, b; Martin et al, 2002).”
BackgroundRole of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · cited 3×
“Manipulation of the endogenous cannabinoid (eCB) system has become a major focus of current research, especially in the search for novel therapeutics to treat many common mental illnesses, including anxiety disorders, depression, and drug addiction (Porter and Felder, 2001; Kathuria et al, 2003).”
BackgroundResultKatona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 2×
“…by the dense expression of the CB1 receptor in regions known to be important for anxiety and emotional learning, including the amygdala, hippocampus, and throughout the mesolimbic dopamine reward system (Katona et al, 1999, 2000, 2001; Freund et al, 2003; van der Stelt and Di Marzo, 2003).”
BackgroundResultMemory Reconsolidation and Extinction Have Distinct Temporal and Biochemical Signatures
Suzuki, A., Josselyn, S. A., Frankland, P. W., Masushige, S., Silva, A. J., & Kida, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5491-03.2004 · Cited by 1,127
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063 · cited 1×
“Follow-up clinical trials have now demonstrated that this approach may be successful in humans as well (Ressler et al, 2004; Rothbaum and Davis, 2003).”
BackgroundSelf-citationMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937 · cited 1×
“These hybridization results are in close agreement with previous studies using immunohistochemical and hybridization techniques (Katona et al, 1999; Marsicano and Lutz, 1999; McDonald and Mascagni, 2001).”
ResultBehavioral and Neural Analysis of Extinction
Myers, K. M., & Davis, M. (2002) · Neuron · doi:10.1016/s0896-6273(02)01064-4 · Cited by 918 · cited 1×
“Reinstatement of fear is one of the principle behavioral processes upon which the idea is based that extinction does not lead to an ‘erasure’ of memory, but rather to a parallel inhibitory process that masks the previous fear memory (for a review, see Myers and Davis, 2002).”
BackgroundSelf-citationWalker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Self-citation
Cited by
Items 401–417 of 417
Llorente Berzal, Á. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The endocannabinoid system: a key modulator of stress effects on memory
Morena, M. (2014) · IRIS Research product catalog (Sapienza University of Rome)
Endocannabinoid Regulation of Learned Fear Inhibition
Warren, W. G. (2023) · Nottingham ePrints (University of Nottingham)
Dry Eye Therapy Using Cannabinoid Ligands
Tran, N. B. (2023) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Cannabidiol regulation of extinction and relapse of learned fear
Papagianni, E. P. (2023) · Nottingham ePrints (University of Nottingham)
Envolvimento do canal TRPV1 no hipocampo na memoria de medo contextual
Iglesias, L. P. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Soncini, F. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Dubreucq, S. (2011) · theses.fr (ABES) · doi:10.70675/c7a188a0z4d25z4c60zb652z8c5e3e4134af
Cell Type-Specific Control of Memory Functions by CB1 Cannabinoid Receptors
Metna‐Laurent, M. (2012) · theses.fr (ABES) · doi:10.70675/9e8f8e45z47c7z4c01zbd94z8f08bdb74cb9
Role of the type-1 cannabinoid receptor in the control of water intake
Zhao, Z. (2019) · theses.fr (ABES) · doi:10.70675/ca103186z8d92z4d94zaf67zcce657f39cd1
Cannabinoid Control of Fear Responses
Landgraf, N. F., Sangroniz-Beltrán, L., Ceprián, M., Reyes-Velásquez, P. A., Huguet, J. E., & Gómez, E. S. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_6
Quillfeldt, J. A., & Alvares, L. D. O. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_3
Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology
Madan, S., El-Khatib, S. M., Prathigudupu, A., Avalos, H. C., Ahmed, F., Piomelli, D., Chan, A., Gupta, K., Jung, K., & Acharya, M. M. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218612
不安症および心的外傷後ストレス障害における 新規治療戦略の確立に向けた δオピオイド受容体の神経薬理学的研究
Kawaminami, A. (2026) · Institutional Repositories DataBase (IRDB) · doi:10.20604/0002000554
Posttraumatische Belastungsstörung
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_7
Metadata
- Authors
- Chhatwal, J. P., Davis, M., Maguschak, K. A., & Ressler, K. J.
- Affiliations
- Emory University (US)
- Corresponding author
- Ressler, Kerry J
- Venue
- Neuropsychopharmacology
- Published
- 2004-12-22
- Volume
- 30
- Issue
- 3
- Pages
- 516-524
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1987096289
- Cited by
- 376
- References
- 49
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 20 · 2022: 7 · 2021: 9 · 2020: 16 · 2019: 12 · 2018: 16 · 2017: 15 · 2016: 19 · 2015: 24 · 2014: 26 · 2013: 23 · 2012: 14
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation
- National Institutes of Health (MH47840)
- National Institute of Mental Health (MH 47840, F30MH070218, MH070218, MH69884, K01MH069884)
- National Institute of General Medical Sciences (T32GM008169)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, fear-potentiated startle, rimonabant, AM404, WIN 55,212-2, fear extinction, anxiety disorders, post-traumatic stress disorder, fear reconsolidation, emotional learning, exposure therapy
- MeSH terms
- Amygdala, Animals, Extinction, Psychological, Fear, Male, Synaptic Transmission, Rats, Sprague-Dawley, In Situ Hybridization, Receptor, Cannabinoid, CB1, Rats, Cannabinoid Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.